Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Enovis CORP

ENOV · NYSE · CIK 0001420800 · Healthcare · Medical Devices

INSIDER SIGNAL

56.7 / 100

2 buyers · 9 purchase transaction lines · $541.7K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeModerate
RoleModerate
RecencyModerate
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+14.0 / 35
Purchase size+14.9 / 25
Role+13.0 / 20
Recency+4.8 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Engert OliverChief Administrative Officer
●●○●●●●●
Ortiz ChristineDirector
○○○
McDonald DamienChief Executive Officer
○●
Wienbar Sharon LDirector
○
Shirley BradyDirector
○
PERFALL A CLAYTONDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 6 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS2
PURCHASE CONCENTRATION54%Largest buyer: Engert Oliver · $292.1K
CLUSTER BUYING · 15D2 insidersPeak activity: 2026-09-02–2026-09-04

Roles in the peak window: Chief Administrative Officer, Chief Executive Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

56.7 / 100

Latest recorded score

↓ -0.2 ptsversus the previous recorded snapshot
  1. 57.3
  2. 57.2
  3. 57.1
  4. 56.9
  5. 56.7

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

18Purchases
4Sales
43Other Form 4 lines
51SEC filings · 365 days
BUYING9 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER14 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-3.9%
3M
-32.6%
6M
-27.6%
12M
-44.3%

Volatility & liquidity

Volatility
55.6%
Beta
—
Avg daily value
USD 26.0M

Valuation

Market cap
USD 1.0B
P/E
—

Fundamentals

Profit margin
-52.7%
ROE
-79.5%
Industry
Medical Devices

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
10,561,633
Previous report
9,483,247
Avg daily volume
1,836,233
Days to cover
5.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-04Engert OliverPurchase (P)Common stock, par value $0.0012,660USD 18.80USD 50,008SEC filing ↗
2026-09-04McDonald DamienPurchase (P)Common stock, par value $0.00113,035USD 19.15USD 249,620SEC filing ↗
2026-09-03Engert OliverPurchase (P)Common stock, par value $0.0015,140USD 19.46USD 100,024SEC filing ↗
2026-09-02Engert OliverPurchase (P)Common stock, par value $0.0012,458USD 20.32USD 49,947SEC filing ↗
2026-06-15Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 20.92USD 20,920SEC filing ↗
2026-06-11Engert OliverPurchase (P)Common stock, par value $0.0011,200USD 21.62USD 25,948SEC filing ↗
2026-06-10Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 23.00USD 23,000SEC filing ↗
2026-06-01Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 22.22USD 22,220SEC filing ↗
2026-03-13Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 23.74USD 23,740SEC filing ↗
2026-03-10Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 23.93USD 23,930SEC filing ↗
2026-03-09Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 23.39USD 23,390SEC filing ↗
2026-03-06Engert OliverPurchase (P)Common stock, par value $0.001750USD 24.41USD 18,310SEC filing ↗
2026-03-04Engert OliverPurchase (P)Common stock, par value $0.001250USD 25.10USD 6,275SEC filing ↗
2026-03-03Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 24.77USD 24,770SEC filing ↗
2026-02-27Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 25.50USD 25,500SEC filing ↗

Form 4 evidence

65 transaction lines in the latest 365-day window; 519 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30Ortiz ChristineAward / grant (A)Common stock, par value $0.001958USD 0.00USD 0SEC filing ↗
2026-09-04Engert OliverPurchase (P)Common stock, par value $0.0012,660USD 18.80USD 50,008SEC filing ↗
2026-09-04McDonald DamienPurchase (P)Common stock, par value $0.00113,035USD 19.15USD 249,620SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30Ortiz ChristineAward / grant (A)Common stock, par value $0.001958USD 0.00USD 0SEC filing ↗
2026-09-04Engert OliverPurchase (P)Common stock, par value $0.0012,660USD 18.80USD 50,008SEC filing ↗
2026-09-04McDonald DamienPurchase (P)Common stock, par value $0.00113,035USD 19.15USD 249,620SEC filing ↗
2026-09-03Engert OliverPurchase (P)Common stock, par value $0.0015,140USD 19.46USD 100,024SEC filing ↗
2026-09-02Engert OliverPurchase (P)Common stock, par value $0.0012,458USD 20.32USD 49,947SEC filing ↗
2026-06-30Ortiz ChristineAward / grant (A)Common stock, par value $0.001846USD 0.00USD 0SEC filing ↗
2026-06-15Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 20.92USD 20,920SEC filing ↗
2026-06-11Engert OliverAward / grant (A)Common stock, par value $0.0011,000USD 20.99USD 20,990SEC filing ↗
2026-06-11Engert OliverPurchase (P)Common stock, par value $0.0011,200USD 21.62USD 25,948SEC filing ↗
2026-06-10Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 23.00USD 23,000SEC filing ↗
2026-06-01Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 22.22USD 22,220SEC filing ↗
2026-05-19Wienbar Sharon LAward / grant (A)Common stock, par value $0.0019,346USD 0.00USD 0SEC filing ↗
2026-05-19Vinnakota RajivAward / grant (A)Common stock, par value $0.0019,346USD 0.00USD 0SEC filing ↗
2026-05-19Shirley BradyAward / grant (A)Common stock, par value $0.0019,346USD 0.00USD 0SEC filing ↗
2026-05-19PERFALL A CLAYTONAward / grant (A)Common stock, par value $0.0019,346USD 0.00USD 0SEC filing ↗
2026-05-19Ortiz ChristineAward / grant (A)Common stock, par value $0.0019,346USD 0.00USD 0SEC filing ↗
2026-05-19Okala PhilipAward / grant (A)Common stock, par value $0.0019,346USD 0.00USD 0SEC filing ↗
2026-05-19Lalor Angela SAward / grant (A)Common stock, par value $0.0019,346USD 0.00USD 0SEC filing ↗
2026-05-19Kelly LiamAward / grant (A)Common stock, par value $0.0019,346USD 0.00USD 0SEC filing ↗
2026-05-19Bodem Barbara W.Award / grant (A)Common stock, par value $0.0019,346USD 0.00USD 0SEC filing ↗
2026-05-12McDonald DamienTax withholding (F)Common stock, par value $0.00112,634USD 25.99USD 328,358SEC filing ↗
2026-05-12BERRY PHILLIP BENJAMIN (BEN)Tax withholding (F)Common stock, par value $0.0017,774USD 25.99USD 202,046SEC filing ↗
2026-03-13Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 23.74USD 23,740SEC filing ↗
2026-03-10Engert OliverPurchase (P)Common stock, par value $0.0011,000USD 23.93USD 23,930SEC filing ↗
2026-03-09VOGT LOUISAward / grant (A)Common stock, par value $0.00136,247USD 0.00USD 0SEC filing ↗
2026-03-09Tandy Bradley JAward / grant (A)Common stock, par value $0.00125,586USD 0.00USD 0SEC filing ↗
2026-03-09ROSS TERRY DAward / grant (A)Common stock, par value $0.00136,247USD 0.00USD 0SEC filing ↗
2026-03-09McDonald DamienAward / grant (A)Common stock, par value $0.001143,923USD 0.00USD 0SEC filing ↗
2026-03-09Lang Patricia AAward / grant (A)Common stock, par value $0.00125,586USD 0.00USD 0SEC filing ↗
2026-03-09KLECKNER JOHNAward / grant (A)Common stock, par value $0.00114,925USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerENOV
CIK0001420800
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
ExchangeNYSE

Data coverage

Local Form 4 history519 transaction lines from 2020-01-02 to 2026-09-30
30 P purchase lines · 131 S sale lines · 358 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.